Pmv Non Current Liabilities Total vs Cash And Short Term Investments Analysis

PMVP Stock

USD 1.39 0.03 2.11%

Pmv Pharmaceuticals financial indicator trend analysis is much more than just breaking down Pmv Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pmv Pharmaceuticals is a good investment. Please check the relationship between Pmv Pharmaceuticals Non Current Liabilities Total and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.

Non Current Liabilities Total vs Cash And Short Term Investments

Non Current Liabilities Total vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pmv Pharmaceuticals Non Current Liabilities Total account and Cash And Short Term Investments. At this time, the significance of the direction appears to have pay attention.

The correlation between Pmv Pharmaceuticals' Non Current Liabilities Total and Cash And Short Term Investments is -0.89. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Pmv Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Pmv Pharmaceuticals' Non Current Liabilities Total and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Pmv Pharmaceuticals are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Non Current Liabilities Total i.e., Pmv Pharmaceuticals' Non Current Liabilities Total and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.89

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Non Current Liabilities Total

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Pmv Pharmaceuticals balance sheet. This account contains Pmv Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Pmv Pharmaceuticals fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Pmv Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pmv Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.At this time, Pmv Pharmaceuticals' Tax Provision is relatively stable compared to the past year. As of 02/17/2025, Issuance Of Capital Stock is likely to grow to about 52.1 M, while Selling General Administrative is likely to drop slightly above 17.1 M.

	2022	2023	2024	2025 (projected)
Interest Income	3.6M	9.8M	11.3M	11.8M
Net Interest Income	3.6M	9.8M	11.3M	11.8M

Interest Income Net Interest Income

Pmv Pharmaceuticals fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital
Total Assets		0.86	0.85	0.99	0.85	0.99	0.71	-0.63	-0.78	0.77	0.68	0.69	0.43	-0.33	0.99	0.88	0.63	-0.92	0.97	0.95	-0.91	0.99	0.69	0.99	0.92	0.99
Other Current Liab	0.86		0.99	0.87	0.89	0.88	0.89	-0.25	-0.94	0.9	0.25	0.89	0.37	-0.58	0.79	0.92	0.87	-0.86	0.84	0.96	-0.83	0.87	0.89	0.79	0.92	0.77
Total Current Liabilities	0.85	0.99		0.85	0.91	0.86	0.9	-0.19	-0.94	0.94	0.23	0.9	0.42	-0.56	0.78	0.94	0.88	-0.83	0.83	0.95	-0.8	0.85	0.9	0.78	0.92	0.76
Total Stockholder Equity	0.99	0.87	0.85		0.81	1.0	0.72	-0.66	-0.78	0.73	0.67	0.69	0.44	-0.32	0.98	0.85	0.64	-0.95	0.98	0.96	-0.95	1.0	0.7	0.98	0.92	0.98
Other Liab	0.85	0.89	0.91	0.81		0.82	0.78	-0.2	-0.84	0.93	0.37	0.79	0.39	-0.52	0.81	0.99	0.75	-0.71	0.83	0.88	-0.68	0.81	0.79	0.81	0.87	0.8
Net Tangible Assets	0.99	0.88	0.86	1.0	0.82		0.72	-0.65	-0.79	0.74	0.65	0.7	0.42	-0.34	0.97	0.86	0.65	-0.95	0.97	0.97	-0.95	1.0	0.71	0.97	0.92	0.97
Property Plant And Equipment Net	0.71	0.89	0.9	0.72	0.78	0.72		-0.01	-0.97	0.85	-0.01	0.96	0.61	-0.58	0.63	0.83	0.98	-0.79	0.73	0.84	-0.76	0.72	1.0	0.64	0.91	0.62
Net Debt	-0.63	-0.25	-0.19	-0.66	-0.2	-0.65	-0.01		0.09	-0.01	-0.9	0.02	-0.12	-0.2	-0.69	-0.22	0.1	0.61	-0.62	-0.47	0.64	-0.66	0.02	-0.69	-0.37	-0.71
Retained Earnings	-0.78	-0.94	-0.94	-0.78	-0.84	-0.79	-0.97	0.09		-0.88	-0.11	-0.95	-0.49	0.65	-0.71	-0.9	-0.94	0.82	-0.8	-0.9	0.8	-0.78	-0.97	-0.71	-0.95	-0.7
Accounts Payable	0.77	0.9	0.94	0.73	0.93	0.74	0.85	-0.01	-0.88		0.19	0.84	0.45	-0.48	0.71	0.95	0.83	-0.65	0.73	0.84	-0.61	0.73	0.85	0.71	0.84	0.69
Cash	0.68	0.25	0.23	0.67	0.37	0.65	-0.01	-0.9	-0.11	0.19		-0.04	0.12	0.23	0.76	0.37	-0.13	-0.49	0.65	0.48	-0.51	0.67	-0.04	0.75	0.37	0.77
Non Current Assets Total	0.69	0.89	0.9	0.69	0.79	0.7	0.96	0.02	-0.95	0.84	-0.04		0.39	-0.76	0.61	0.83	0.99	-0.76	0.67	0.81	-0.73	0.69	0.98	0.62	0.89	0.6
Non Currrent Assets Other	0.43	0.37	0.42	0.44	0.39	0.42	0.61	-0.12	-0.49	0.45	0.12	0.39		0.21	0.42	0.41	0.49	-0.47	0.54	0.46	-0.46	0.44	0.56	0.43	0.54	0.42
Other Assets	-0.33	-0.58	-0.56	-0.32	-0.52	-0.34	-0.58	-0.2	0.65	-0.48	0.23	-0.76	0.21		-0.26	-0.55	-0.68	0.41	-0.29	-0.46	0.39	-0.32	-0.65	-0.26	-0.55	-0.24
Cash And Short Term Investments	0.99	0.79	0.78	0.98	0.81	0.97	0.63	-0.69	-0.71	0.71	0.76	0.61	0.42	-0.26		0.84	0.55	-0.89	0.96	0.91	-0.89	0.98	0.62	1.0	0.88	1.0
Common Stock Shares Outstanding	0.88	0.92	0.94	0.85	0.99	0.86	0.83	-0.22	-0.9	0.95	0.37	0.83	0.41	-0.55	0.84		0.79	-0.77	0.87	0.92	-0.74	0.85	0.83	0.84	0.92	0.83
Short Term Investments	0.63	0.87	0.88	0.64	0.75	0.65	0.98	0.1	-0.94	0.83	-0.13	0.99	0.49	-0.68	0.55	0.79		-0.73	0.63	0.78	-0.69	0.64	0.99	0.56	0.86	0.53
Non Current Liabilities Total	-0.92	-0.86	-0.83	-0.95	-0.71	-0.95	-0.79	0.61	0.82	-0.65	-0.49	-0.76	-0.47	0.41	-0.89	-0.77	-0.73		-0.93	-0.94	1.0	-0.95	-0.78	-0.89	-0.94	-0.89
Other Current Assets	0.97	0.84	0.83	0.98	0.83	0.97	0.73	-0.62	-0.8	0.73	0.65	0.67	0.54	-0.29	0.96	0.87	0.63	-0.93		0.95	-0.92	0.98	0.71	0.96	0.93	0.96
Other Stockholder Equity	0.95	0.96	0.95	0.96	0.88	0.97	0.84	-0.47	-0.9	0.84	0.48	0.81	0.46	-0.46	0.91	0.92	0.78	-0.94	0.95		-0.92	0.96	0.83	0.92	0.96	0.9
Total Liab	-0.91	-0.83	-0.8	-0.95	-0.68	-0.95	-0.76	0.64	0.8	-0.61	-0.51	-0.73	-0.46	0.39	-0.89	-0.74	-0.69	1.0	-0.92	-0.92		-0.95	-0.75	-0.89	-0.92	-0.88
Net Invested Capital	0.99	0.87	0.85	1.0	0.81	1.0	0.72	-0.66	-0.78	0.73	0.67	0.69	0.44	-0.32	0.98	0.85	0.64	-0.95	0.98	0.96	-0.95		0.7	0.98	0.92	0.98
Property Plant And Equipment Gross	0.69	0.89	0.9	0.7	0.79	0.71	1.0	0.02	-0.97	0.85	-0.04	0.98	0.56	-0.65	0.62	0.83	0.99	-0.78	0.71	0.83	-0.75	0.7		0.62	0.91	0.6
Total Current Assets	0.99	0.79	0.78	0.98	0.81	0.97	0.64	-0.69	-0.71	0.71	0.75	0.62	0.43	-0.26	1.0	0.84	0.56	-0.89	0.96	0.92	-0.89	0.98	0.62		0.88	1.0
Non Current Liabilities Other	0.92	0.92	0.92	0.92	0.87	0.92	0.91	-0.37	-0.95	0.84	0.37	0.89	0.54	-0.55	0.88	0.92	0.86	-0.94	0.93	0.96	-0.92	0.92	0.91	0.88		0.87
Net Working Capital	0.99	0.77	0.76	0.98	0.8	0.97	0.62	-0.71	-0.7	0.69	0.77	0.6	0.42	-0.24	1.0	0.83	0.53	-0.89	0.96	0.9	-0.88	0.98	0.6	1.0	0.87

Click cells to compare fundamentals

Pmv Pharmaceuticals Account Relationship Matchups

Pmv Pharmaceuticals fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	365.5M	331.6M	270.3M	252.2M	290.0M	254.1M
Other Current Liab	4.8M	8.2M	6.8M	9.9M	11.4M	6.0M
Total Current Liabilities	6.4M	12.2M	10.8M	14.0M	16.1M	9.2M
Total Stockholder Equity	359.1M	308.6M	246.0M	225.7M	259.5M	187.5M
Net Tangible Assets	(70.5M)	359.1M	308.6M	246.0M	282.9M	175.4M
Property Plant And Equipment Net	569K	13.2M	20.5M	19.0M	21.9M	23.0M
Net Debt	(361.4M)	(161.3M)	(94.3M)	(24.4M)	(22.0M)	(23.1M)
Retained Earnings	(109.9M)	(167.7M)	(241.0M)	(310.0M)	(279.0M)	(265.1M)
Accounts Payable	1.6M	3.2M	3.0M	3.2M	3.7M	2.7M
Cash	361.4M	172.5M	108.3M	37.7M	33.9M	32.2M
Non Current Assets Total	770K	30.3M	23.3M	44.7M	51.5M	54.0M
Cash And Short Term Investments	361.4M	297.2M	241.1M	203.1M	233.5M	232.1M
Common Stock Shares Outstanding	44.8M	45.1M	45.6M	48.0M	55.2M	47.3M
Short Term Investments	0.0	124.7M	132.8M	165.4M	190.2M	199.7M
Liabilities And Stockholders Equity	365.5M	331.6M	270.3M	252.2M	290.0M	254.1M
Non Current Liabilities Total	1.6M	10.8M	13.4M	12.4M	11.2M	10.6M
Other Current Assets	6.7M	4.1M	6.0M	4.4M	5.0M	4.0M
Other Stockholder Equity	469.0M	476.4M	487.5M	535.5M	615.8M	362.5M
Total Liab	6.4M	23.0M	24.3M	26.5M	23.8M	22.6M
Net Invested Capital	359.1M	308.6M	246.0M	225.7M	259.5M	187.5M
Property Plant And Equipment Gross	569K	13.2M	20.5M	22.3M	25.7M	26.9M
Total Current Assets	364.8M	301.3M	247.0M	207.4M	238.5M	235.5M
Net Working Capital	358.4M	289.1M	236.2M	193.4M	222.4M	226.3M
Property Plant Equipment	739K	569K	13.2M	11.0M	12.6M	13.2M

Additional Tools for Pmv Stock Analysis

When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pmv Non Current Liabilities Total vs Cash And Short Term Investments Analysis

Non Current Liabilities Total vs Cash And Short Term Investments

Non Current Liabilities Total vs Cash And Short Term Investments Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Cash And Short Term Investments

Pmv Pharmaceuticals fundamental ratios Correlations

Pmv Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pmv Pharmaceuticals fundamental ratios Accounts

Additional Tools for Pmv Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments

Property Plant And Equipment Gross	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Property Plant And Equipment Net
Net Invested Capital	- 0.95	Total Liab
Net Invested Capital	- 0.95	Non Current Liabilities Total
Non Current Liabilities Other	- 0.95	Retained Earnings
Non Current Assets Total	- 0.95	Retained Earnings